Journal of Substance Abuse Treatment
Volume 37, Issue 3 , Pages 247-255 , October 2009

Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking

  • Peter Gariti, Ph.D.

      Affiliations

    • Department of Psychiatry, Center for the Study of Addictions, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    • Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    • Corresponding Author InformationCorresponding author. University of Pennsylvania Treatment Research Center, Philadelphia, PA, USA. Tel.: +1 610 935 1929; fax: +1 610 933 0471.
    • ,
  • Kevin Lynch, Ph.D.

      Affiliations

    • Department of Psychiatry, Center for the Study of Addictions, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    • ,
  • Arthur Alterman, Ph.D.

      Affiliations

    • Department of Psychiatry, Center for the Study of Addictions, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    • ,
  • Klye Kampman, M.D.

      Affiliations

    • Department of Psychiatry, Center for the Study of Addictions, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    • ,
  • Hu Xie, M.S.

      Affiliations

    • Department of Psychiatry, Center for the Study of Addictions, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    • ,
  • Kristi Varillo, M.S.

      Affiliations

    • Department of Psychiatry, Center for the Study of Addictions, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA

Received 22 September 2008 ,Revised 22 January 2009 ,Accepted 26 January 2009.

References 

  1. Anton R, O'Malley SS, Ciraulo DA, Coupler RA, Donovan DM, Gastfriend DR, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. Journal of the American Medical Association. 2006;295:2003–2017
  2. Choi W, Okuyemi K, Kaur J, Ahluwalia JS. Comparisons of smoking relapse curves among African Americans. Addictive Behaviors. 2004;29:1679–1683
  3. Fargas AJ. When does cigarette fading increase the likelihood of future cessation?. Annals of Behavioral Medicine. 1999;21:71–76
  4. First MB, Spitzer RL, Gibbon M, Williams J. Structured Clinical Interview for Axis I DSM-IV Disorders. New York, NY: Biometrics Research Department; 1994;
  5. Fiore MC, et al. A clinical practice guideline for treating tobacco use and dependence. U.S. Public Health Service Report, Clinical Practice Panel. Journal of the American Medical Association. 2000;283:3244–3254
  6. Fiore MC, Smith SS, Jorenby DE, Baker T. The effectiveness of the nicotine patch for smoking cessation. Journal of the American Medical Association. 1994;271:1940–1947
  7. Gariti PW, Alterman AI, Ehrman R, Pettinati H. Reliability and validity of the aggregate method for determining cigarettes smoked per day. American Journal of Addictions. 1998;7:283–287
  8. Gariti PW, Levin S, Whttingham T, Barou D, Kampman K, Lynch K, et al. Why do those who request smoking treatment fail to attend the first appointment?. Journal of Substance Abuse Treatment. 2008;35:62–67
  9. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, et al. Varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation—A randomized controlled trial. Journal of the American Medical Association. 2006;296:47–55
  10. Heatherton TD, Kozlowski LT, Frecker RC, Fagerstrom K. The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance test. British Journal of Addiction. 1991;86:1119–1127
  11. Hughes JR, Hutsukami D. Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry. 1984;43:289–294
  12. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: Issues and recommendations. Nicotine and Tobacco Research. 2003;5:13–25
  13. Hurt RD, Croghan GA, Wolter TD, Croghan IT, Offord KP, Williams GM, et al. Does smoking reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine and Tobacco Research. 2000;2:327–336
  14. Hurt RD, Sachs DPL, Glover ED, Offord KP, Johnston JA, Dale LC, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine. 1997;337:1195–1202
  15. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. A controlled trial of sustained release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine. 1999;340:685–691
  16. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. Journal of the American Medical Association. 2006;296:56–63
  17. Mayo . Smoke-Free and Living It. Mayo Foundation for Medical Education and Research. Rochester, Minnesota: Mayo Press; 2000;
  18. McWorter WP, Boyd GM, Mattson ME. Predictors of quitting smoking: The NANES I follow-up experience. Journal of Clinical Epidemiology. 1990;43:1399–1405
  19. Pierce JP, Gilpin EA. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. Journal of theAmerican Medical Association. 2002;288:1260–1264
  20. Prochaska JO, DiClemente CC. The transtheoretical approach: Crossing traditional boundaries of therapy. Homewood, IL: Dow Jones, Irwin; 1984;
  21. Radloff LS. The CES-D: A self-report depression scale for research in the general Population. Applied Psychological Measurement. 1977;1:385–401
  22. Sheenan DV, Lecrubier Y, Sheehan K, Janavs J, Weiller A, Schihnka J, et al. The validity of the Mini International Interview (MINI) according to the SCID-P and its reliability. European Psychiatry. 1997;12:232–241
  23. Shiffman S. Nicotine lozenge in light smokers. Drug and Alcohol Dependence. 2005;77:311–314
  24. Spitzer RL, Williams JB, Gibbon M, First BB. Structured clinical interview for DSM-III-R with Psychotic Screen)—Version 1.0. Washington, DC: American Psychiatric Press, Inc; 1990;
  25. Sobell LC, Maisto SA, Sobell MB, Cooper AM. Reliability of alcohol abusers' self-report of drinking behavior. Behavior Research and Therapy. 1979;17:157–160
  26. Stout RL, Wirtz PW, Carbonari JP, Del Boca FK. Ensuring balanced distribution of prognostic factors in treatment outcome research. Journal Studies of Alcohol. 1994;(Supplement No. 12):70–75
  27. The Tobacco Use and Dependence Guideline Panel, Staff, and Consortium Representatives . A clinical practice guideline for treating tobacco use and dependence. Journal of the American Medical Association. 2000;283:3244–3254
  28. U.S. Department of Health and Human Services . Clearing the air: Quit smoking today. Bethesda, MD: National Cancer Institute; 2004;
  29. U.S. Department of Health and Human Services, Centers for Disease Control . Cigarette smoking among adults—United States 2004. MMWR. Morbidity and Mortality Weekly Report. 2005;54:121–1124
  30. U.S. Department of Health and Human Services, Centers for Disease Control . Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General, 1989. Rockville, MD: Centers for Disease Control, PHS 88-8411; 1989;
  31. Wei LJ. An application of an urn model to the design of sequential controlled trials. Journal American Statistical Association. 1978;73:559–563Design. British Journal of Addiction, 86, 205–215
  32. Yates AJ, Thain J. Self-efficacy as a predictor of relapse following voluntary cessation of smoking. Addiction Behavior. 1985;10:291–298

 All work was performed at the University of Pennsylvania.

PII: S0740-5472(09)00012-9

doi: 10.1016/j.jsat.2009.01.006

Journal of Substance Abuse Treatment
Volume 37, Issue 3 , Pages 247-255 , October 2009

Article Tools